Gut Bacteria Hijack Your Own Sex Hormones to Control Bowel Movement
Your gut bacteria don't just digest food; they also reactivate sex hormones that tell your intestines how fast to move. A new study in Nature Neuroscience reveals the precise enzymatic mechanism behind this surprising circuit.
Gut bacteria are already known to influence mood, immunity, and metabolism, but a study published in Nature Neuroscience has now identified a more startling role: resident microbes reactivate the body's own androgens inside the colon, and those hormones directly tune the nerve cells that drive intestinal movement. The findings add a concrete molecular mechanism to what has long been a fuzzy idea, that the microbiome and the gut's nervous system talk to each other.
Microbial Beta-Glucuronidase Enzymes Unlock Inactive Androgens
Androgens such as testosterone are steroid hormones traditionally associated with male reproductive traits, but they circulate in both sexes and influence tissues throughout the body. The body marks used androgens for excretion by attaching a glucuronic acid molecule, a process called glucuronidation, which makes the hormone water-soluble enough to flush out in urine or bile. What this new research from Lagomarsino, Robinson, and Mitchell demonstrates is that gut bacteria carry beta-glucuronidase (GUS) enzymes that clip off that glucuronic acid tag, releasing free, biologically active androgens right inside the colon.
This is not a generic microbial trick. The team found that distinct GUS subfamilies show clear substrate preferences: Loop 1 GUS enzymes, for instance, preferentially deconjugate testosterone-glucuronide. That specificity matters because it means the microbiome is not just passively leaking hormones but performing targeted enzymatic conversions. Earlier work had already shown that the gut microbiota regulates intestinal androgen metabolism and can generate high concentrations of free testosterone and dihydrotestosterone in the colon, but the new study traces the downstream consequence of that chemistry all the way to neuronal firing patterns.
Androgen Signaling to NOS1 Neurons Drives Normal Intestinal Transit
About 95 percent of androgen receptor-positive enteric neurons in the male murine colon carry NOS1 immunoreactivity, marking them as inhibitory motor neurons. These are cells whose activity shapes peristaltic timing: when they fire, they modulate smooth muscle contractions that push contents through the intestine. The study found that androgen signaling to this Nos1-positive population is required for normal intestinal transit in male mice. When microbes were wiped out using broad-spectrum antibiotics, androgen receptor expression in enteric neurons dropped, serum testosterone fell, and the mice developed dysmotility.
The link to neuronal excitability was confirmed with advanced imaging. Enhanced androgen availability correlated with increased calcium fluxes and higher action potential frequency in enteric ganglia, concrete electrophysiological evidence that the hormone is functionally active on these neurons, not merely present. The enteric nervous system's central role in controlling gut motility has been documented extensively, but identifying a microbially supplied ligand that tunes its output is a new step.
Restoring GUS Activity Rescues Dysmotility in Antibiotic-Treated Mice
One of the study's sharpest experiments was a rescue. After depleting gut microbes with antibiotics and watching intestinal transit deteriorate, the researchers administered a GUS enzyme directly into the colon. That single intracolonic intervention restored neuronal androgen signaling and reversed the motility deficits. The effect was also replicated by androgen supplementation in microbe-depleted animals. Together, the two rescue strategies isolate the enzymatic reactivation of androgens as the operative step in the microbiome-to-neuron chain, rather than some other microbial product.
Shotgun metagenomics of stool identified the bacterial taxa carrying these GUS enzymes, giving the team a list of microbial players to investigate further. The methods combined metabolomic profiling, genetic manipulation, pharmacological tools, and mouse genetic knockouts, a multi-modal approach that advanced microbiome research methods such as germ-free animal models have made feasible at this level of resolution.
Why This Circuit Appears Sex-Specific and Colon-Restricted
Androgen signaling had essentially no detectable effect on GI motility in the female murine colon under the conditions tested, a finding the authors flag as important but currently unexplained. This sex difference mirrors what has been observed clinically: sex hormones influence IBS symptoms differently across sexes, with conditions like irritable bowel syndrome showing marked male-female disparities in prevalence and character. If microbially reactivated androgens are a meaningful driver of colonic transit in males, it may help explain why gut motility disorders present differently between men and women.
Why the pathway appears localized to the colon rather than the small intestine also remains open. Androgen dysregulation has been implicated in IBS, polycystic ovarian syndrome, and prostate cancer, so the tissue specificity question has real clinical weight. The authors call for further work to determine whether dietary changes, antibiotics, or microbiota transplants might inadvertently shift GUS enzyme activity and, by extension, colonic transit.
Microbiota-Targeted Treatments for Gut Motility Are Now a Realistic Goal
The study's practical horizon is visible even at this early stage. If specific bacterial GUS enzymes are the key link between microbiome composition and enteric neuronal tone, then selectively modulating those enzymes becomes a tractable therapeutic target. Microbiota-targeted therapies for gut motility, including prebiotics, probiotics, and fecal microbiota transplantation, are already under investigation for conditions like constipation and IBS, but they have lacked mechanistic precision. Knowing that GUS-driven androgen reactivation is one specific lever that controls inhibitory motor neuron output gives researchers a defined target to hit or avoid.
The broader implication is that the gut microbiome functions, in part, as a local endocrine organ, converting inactivated hormones back into signaling molecules that the host's own nervous system then reads. Decoding which microbial enzymes perform which conversions, and in which tissue compartments, could eventually reshape how clinicians think about gut disorders that have resisted explanation through conventional gastroenterology.
